Casticin induces apoptosis and cytoprotective autophagy while inhibiting stemness involving Akt / mTOR and JAK2 / STAT3 pathways in glioblastoma
Phytotherapy Research · 2024
DOI: 10.1002/ptr.8048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytotherapy Research, 2024. Verfasst von Xun Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traumatic Orthopedics, Shenzhen Second People's Hospital (The First Affiliated Hospital, Shenzhen University; School of Biomedical Engi…. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Flavonoids. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Glioblastoma (GBM) is the most common malignant glioma. However, the current systemic drugs cannot completely cure GBM. Casticin is a methoxylated flavonol compound isolated from a traditional Chinese medicine Vitex rotundifolia L.f. and exhibits a strong antitumor activity in multiple human malignancies. This study was aimed to explore the effects and underlying mechanisms of casticin in GBM. The MTT assay and colony formation was used to evaluate the casticin‐induced cell viability in GBM cells. Apoptosis was assessed by ANNEXIV/PI staining assay. Autophagy was analyzed by transmission electron microscopy and immunofluorescence assays. GBM stem cell (GSC) was analyzed by tumor‐sphere formation assay and ALDEFLUOR assay. The anti‐GBM effect of casticin was also determined by the U87MG xenograft model. Casticin inhibited tumor cell growth in vitro and in vivo, as well as significantly induced apoptosis and autophagy. Autophagy inhibition augmented casticin‐induced apoptosis. Casticin also reduced the GSC population by suppressing Oct4, Nanog, and Sox2. Mechanistically, casticin inhibited Akt/mTOR and JAK2/STAT3 signal pathways. The antitumor effect of casticin in GBM was demonstrated by inducing apoptosis, autophagy, and reducing population of GSCs; thus, it may be a potential GBM therapeutic agent for future clinical usage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Traumatic Orthopedics, Shenzhen Second People's Hospital (The First Affiliated Hospital, Shenzhen University; School of Biomedical Engineering, Shenzhen University Medical School), Shenzhen, China.
- Department of Spine Surgery, Shanghai Tenth People's Hospital, Tongji University, Shanghai, China.
- Department of Orthopedics, Shanxi Bethune Hospital, Taiyuan City, China.
- Department of Hand & Microvascular Surgery, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Chi…
ORCID-Profile: Lijun Liu
Zitieren
APA
Yang, X., Liu, Z., Xu, X., He, M., Xiong, H., & Liu, L. (2024). Casticin induces apoptosis and cytoprotective autophagy while inhibiting stemness involving Akt / mTOR and JAK2 / STAT3 pathways in glioblastoma. Phytotherapy Research. https://doi.org/10.1002/ptr.8048
Vancouver
Yang X, Liu Z, Xu X, He M, Xiong H, Liu L. Casticin induces apoptosis and cytoprotective autophagy while inhibiting stemness involving Akt / mTOR and JAK2 / STAT3 pathways in glioblastoma. Phytotherapy Research. 2024. doi:10.1002/ptr.8048
BibTeX
@article{Yang2024,
author = {Yang, Xun and Liu, Zeyuan and Xu, Xu and He, Meng and Xiong, Hongtao and Liu, Lijun},
title = {Casticin induces apoptosis and cytoprotective autophagy while inhibiting stemness involving Akt / mTOR and JAK2 / STAT3 pathways in glioblastoma},
journal = {Phytotherapy Research},
year = {2024},
doi = {10.1002/ptr.8048}
}
EUVIMED